Showing all results Page 2 of 16

Vietnam’s IVD market – sample report

February 7th, 2024

Vietnam’s IVD market is expected to increase by 2.5% in the next five years. But what’s the outlook for the diagnostics industry, and what trends are shaping market demand and future growth across vital IVD segments?

  • Campaign
  • In-vitro diagnostics
  • Point-of-care testing (POCT)
  • Asia
  • Vietnam

Point-of-care testing for infectious diseases

January 24th, 2024

In a recent Q&A interview with Clearstate’s global managing director, Ivy Teh, we talked about the future of point-of-care testing (POCT) and other opportunities in the global market for testing of other infectious diseases.

  • Clearstate Insights
  • In-vitro diagnostics
  • Point-of-care testing (POCT)
  • Global
  • IVD Gateway
  • Point-of-care testing (POCT)

What technology will revolutionise the point-of-care testing market?

January 22nd, 2024

In a recent Q&A interview, Clearstate’s global managing director, Ivy Teh, talks about the importance of new technologies in the adoption of point-of-care testing.

  • Clearstate Insights
  • In-vitro diagnostics
  • Point-of-care testing (POCT)
  • Global
  • Point-of-care testing (POCT)

Brazil’s IVD market – sample report

December 5th, 2023

Brazil has faced significant challenges during the coronavirus pandemic, with the high mortality ranked second only to the United States. The country’s healthcare system, which has long suffered from inadequate funding, has struggled to cope with the crisis, exacerbated by a weak government response. In response to the emergence of the more contagious Omicron variant, the government implemented travel bans and other restrictions in December 2021.

  • Campaign
  • In-vitro diagnostics
  • Americas

Essential insights into Vietnam’s in-vitro diagnostics market

November 3rd, 2023

Vietnam’s IVD market, estimated at US$419.2m, faced a significant decline in 2022 from the previous year’s market size. This is caused by a decrease in point-of-care (POC) and molecular diagnostics (MDx) segments and fewer rapid antigen tests as pandemic restrictions were lifted.

  • Campaign
  • Centralised Diagnostics (CEDx)
  • In-vitro diagnostics
  • Infectious Diseases Testing Monitor
  • Point-of-care testing (POCT)
  • Asia
  • Vietnam

Healthcare outlook 2024

November 1st, 2023

A recovery in the global economy will cause a return to spending growth in the healthcare sector. However, it will remain vulnerable to headwinds, including limited resources, stricter regulations and continued strikes.

  • Campaign
  • Cardiovascular surgery
  • Centralised Diagnostics (CEDx)
  • Covid-19 testing
  • General surgery
  • In-vitro diagnostics
  • Infectious Diseases Testing Monitor
  • Next Generation Sequencing (NGS)
  • Surgical device
  • Global